AgeX Therapeutics, Inc.

    Jurisdiction
    United States
    ISIN
    US00848H1086 (AGE)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9

    Profile

    AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €80.22K
    Gross margin
    -43.0%
    EBIT
    -€22.04M
    EBIT margin
    -27,468.8%
    Net income
    -€2.33M
    Net margin
    -2,901.1%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Moreadith Randall Chief Scientific Officer -48K $6.95 -$331.33K
    Moreadith Randall Chief Scientific Officer -4.3K $5.18 -$22.29K
    Moreadith Randall Chief Scientific Officer -5.5K $5.25 -$28.88K
    Moreadith Randall Chief Scientific Officer -5.5K $5.17 -$28.44K
    Moreadith Randall Chief Scientific Officer -4.2K $6.50 -$27.27K

    Add to watchlist

    Notifications